5Q0C
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate
Experimental procedure
| Experimental method | SINGLE WAVELENGTH | 
| Source type | SYNCHROTRON | 
| Source details | SLS BEAMLINE X10SA | 
| Synchrotron site | SLS | 
| Beamline | X10SA | 
| Temperature [K] | 100 | 
| Detector technology | CCD | 
| Collection date | 2006-06-12 | 
| Detector | MAR CCD 165 mm | 
| Wavelength(s) | 0.987 | 
| Spacegroup name | C 2 2 21 | 
| Unit cell lengths | 222.475, 240.518, 138.979 | 
| Unit cell angles | 90.00, 90.00, 90.00 | 
Refinement procedure
| Resolution | 29.793 - 2.400 | 
| R-factor | 0.1703 | 
| Rwork | 0.168 | 
| R-free | 0.21030 | 
| Structure solution method | MOLECULAR REPLACEMENT | 
| RMSD bond length | 0.008 | 
| RMSD bond angle | 0.960 | 
| Refinement software | PHENIX (1.11.1_2575) | 
Data quality characteristics
| Overall | |
| Low resolution limit [Å] | 29.793 | 
| High resolution limit [Å] | 2.400 | 
| Number of reflections | 141184 | 
| Completeness [%] | 97.5 | 
Crystallization Conditions
| crystal ID | method | pH | temperature | details | 
| 1 | VAPOR DIFFUSION, SITTING DROP | entry deposited much later from experimental date, thus exact crystallization details not known | 











